Areva's 10% blocking shareholding will be a limit to an extent ... share rise is perhaps due to the incredibly illiquid situation?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025